Library / regulatory-reference
Brunei: Ministry of Health Pharmaceutical Services
Audience: administrators-policy, researchers-scientists ยท Review state: published
The national authority
In Brunei Darussalam, medicines regulation sits within the Ministry of Health, which oversees the registration, import and supply of pharmaceutical products.
As a small national market, Brunei draws on assessments from established regulators and regional cooperation among Southeast Asian states to support its decisions.
How products enter the market
Medicines are registered by the ministry after review of quality, safety and efficacy, and importers and suppliers are licensed.
Post-market work includes adverse-reaction monitoring, quality surveillance and public notices on product safety.
Regional and international role
The ministry takes part in regional harmonization work among Southeast Asian health authorities.
Its reliance on shared regional assessment makes it a useful example of regulation in a small market.
Using this profile
Regulations, registers and notices are published in English and Malay through the official portal, which is the primary source for current rules and listed in this profile's internal reference record.
For cross-country comparison: Brunei illustrates small-market regulation: ministry-run registration that leans on regional and peer assessments.
Limitations
Educational profile of a national regulatory system, current as of drafting. It simplifies routes and classes and is not legal, regulatory, or clinical advice. Filing and compliance decisions must be confirmed against the authority's current published rules and, where needed, professional regulatory counsel.